These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of Dermatomyositis and Immune-Mediated Necrotizing Myopathy with Poor Muscle Recovery with Steroids and IVIg: Intractable Dermatomyositis and Immune-Mediated Necrotizing Myopathy]. Sugie K. Brain Nerve; 2022 May; 74(5):537-544. PubMed ID: 35589644 [Abstract] [Full Text] [Related]
4. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis]. Cherin P. Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990 [Abstract] [Full Text] [Related]
16. Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology. Sunderkötter C, Nast A, Worm M, Dengler R, Dörner T, Ganter H, Hohlfeld R, Melms A, Melzer N, Rösler K, Schmidt J, Sinnreich M, Walter MC, Wanschitz J, Wiendl H. J Dtsch Dermatol Ges; 2016 Mar; 14(3):321-38. PubMed ID: 26972210 [Abstract] [Full Text] [Related]
17. Corticosteroids in Myositis and Scleroderma. Postolova A, Chen JK, Chung L. Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554 [Abstract] [Full Text] [Related]